Related references
Note: Only part of the references are listed.Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Florence T. Bourgeois et al.
ANNALS OF INTERNAL MEDICINE (2010)
Is the Incidence of Rheumatoid Arthritis Rising? Results From Olmsted County, Minnesota, 1955-2007
Elena Myasoedova et al.
ARTHRITIS AND RHEUMATISM (2010)
Registering Clinical Trial Results The Next Step
James Dabney Miller
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis
S. M. van der Kooij et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Need for Improved Access to FDA Reviews
Alec B. O'Connor
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Treatment of rheumatoid arthritis: state of the art 2009
Ronald F. van Vollenhoven
NATURE REVIEWS RHEUMATOLOGY (2009)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial
EWS Clair et al.
ARTHRITIS AND RHEUMATISM (2004)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
J Lexchin et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
JM Bathon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
